Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StemEx in Hematologic Malignancies (ExCell)
NCT00469729Phase 3Completed
- Start
- Oct 2007
- Primary completion
- Feb 2013
- Modality
- Stem Cell Therapies
- Countries
- 5
01
Overview
A Phase 3 trial of carlecortemcel-l in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL). Started Oct 2007; status: completed.
02
Drugs
carlecortemcel-l
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00469729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469729.